为您找到相关结果约500个

你是不是要搜索 期刊1-6型慢性丙型肝炎病毒(HCV)感染 点击跳转

Sofosbuvir susceptibility of genotype 1 to 6 HCV from DAA-naive subjects

Performance of 6 HCV genotyping 9G test for HCV genotyping in clinical samples

In vitro selection of resistance to sofosbuvir in HCV replicons of genotype-1 to-6

Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis

Safety and efficacy of glecaprevir/pibrentasvir for the treatment of HCV genotype 1-6: Results of theHCV-TARGET study

SAFETY AND EFFICACY OF GLECAPREVIR/PIBRENTASVIR FOR THE TREATMENT OF HCV GENOTYPE 1-6: RESULTS OF THEHCV-TARGET STUDY

Genotype 6 Hepatitis C virus (HCV) infection is associated with lower odds of cirrhosis compared to genotype1 HCV infection

HCV genotype 1-6 NS3 residue 80 substitutions impact protease inhibitor activity and promote viral escape

Hepatitis C viral load in HCV-monoinfected and HCV/HIV-1-, HCV/HTLV-1/-2-, and HCV/HIV/HTLV-1/-2-co-infected

Efficacy and safety of 6 or 8weeks of simeprevir, daclatasvir, sofosbuvir for HCV genotype 1 infection

6 HCV Genotyping 9G test for HCV 1a, 1b, 2, 3, 4 and 6 (6a, 6f, 6i and 6n) with high accuracy

Safety and Efficacy of Velpatasvir and Sofosbuvir-based Regimens for the Treatment of HCV Genotype 1-6: Results of the HCV-TARGET Study

SAFETY AND EFFICACY OF SOFOSBUVIR/VELPATASVIR/VOXILAPREVIR-BASED REGIMENS FOR THE TREATMENT OF HCV GENOTYPE1-6: RESULTS OF THE HCV-TARGET COHORT

The New Aptima HCV Quant Dx Real-time TMA Assay Accurately Quantifies Hepatitis C Virus Genotype 1-6

Resistance analysis in patients with genotype 1-6 HCV infection treated with sofosbuvir/velpatasvir in

为您找到相关结果约500个

共500条页码: 1/34页15条/页